Radiation therapy for bladder cancer

Radiation therapy uses high-energy rays or particles to destroy cancer cells. It is sometimes used to treat bladder cancer. Your healthcare team will consider your personal needs to plan the type and amount of radiation, and when and how it is given. You may also receive other treatments.

Radiation therapy is often combined with chemotherapy to treat bladder cancer. This is called chemoradiation. The 2 treatments are given during the same time period.

Radiation therapy is given for different reasons. You may have chemoradiation or radiation therapy to:

  • destroy cancer cells in the body
  • prevent the whole bladder from being removed
  • destroy cancer cells left behind after surgery to reduce the risk that the cancer will come back (recur) (called adjuvant therapy)
  • relieve pain or control the symptoms of advanced bladder cancer (called palliative therapy)

The following types of radiation therapy are most commonly used to treat bladder cancer.

External radiation therapy

During external radiation therapy (also called external beam radiation therapy), a machine directs radiation through the skin to the area with the cancer and some of the tissue around it.

External radiation therapy is most often used as a part of chemoradiation to treat bladder cancer that has grown into the muscle layer of the bladder wall (muscle-invasive bladder cancer) so the bladder doesn’t have to be removed. This is called a bladder-preserving approach. The chemoradiation is given after surgery with a transurethral resection of bladder tumour (TURBT). During treatment, the radiation is given to the whole bladder and nearby lymph nodes in the pelvis.

External radiation therapy may be used alone when surgery can’t be done (the cancer is unresectable) or to control bleeding from the bladder. It can also be used to treat other parts of the body where the cancer has spread (metastatic cancer), such as bone. Find out more about metastatic cancer.

External radiation therapy is usually given 5 days a week for 1 to 2 months. It may be given for a shorter amount of time when used as palliative therapy.

Side effects

Side effects can happen with any type of treatment for bladder cancer, but everyone’s experience is different. Some people have many side effects. Other people have few or none at all.

During radiation therapy, the healthcare team tries to protect healthy cells in the treatment area as much as possible. But damage to healthy cells can happen and may cause side effects. If you develop side effects, they can happen any time during, immediately after or a few days or weeks after radiation therapy. Sometimes late side effects develop months or years after radiation therapy. Most side effects go away on their own or can be treated, but some side effects may last a long time or become permanent.

Side effects of radiation therapy will depend mainly on the size of the area being treated, the specific area or organs being treated, the total dose of radiation and the treatment schedule. Some common side effects of radiation therapy for bladder cancer are:

Tell your healthcare team if you have these side effects or others you think might be from radiation therapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Questions to ask about radiation therapy

Find out more about radiation therapy and side effects of radiation therapy. To make the decisions that are right for you, ask your healthcare team questions about radiation therapy.

Expert review and references

  • Alberta Health Services. Muscle Invasive and Locally Advanced/Metastatic Bladder Cancer Clinical Practice Guideline GU-002 (Version 5). Alberta Health Services; 2013. https://www.albertahealthservices.ca/.
  • American Cancer Society. Treating Bladder Cancer. 2016. https://www.cancer.org/.
  • American Society of Clinical Oncology. Bladder Cancer. 2017.
  • Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. Journal of Urology. 2017.
  • Feldman AS, Efstathiou JA, Lee RJ, Dahl DM, Michaelson MD, Zietman AL. Cancer of the bladder, ureter, and renal pelvis. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 65:896-916.
  • National Cancer Institute. Bladder Cancer Treatment (PDQ®) Health Professional Version. 2018. https://www.cancer.gov/.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (Version 5.2018).

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society